Search companies

Live

Tuesday, 17 November 2026 · 578 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

PYC Shareholders Approve Director Rights, But CEO Options Draw More Opposition

PYC: $1.91 +0.52% · MC: $1.9B

PYC Therapeutics shareholders passed all resolutions at the 2026 AGM, including awards of restricted and performance rights to CEO Rohan Hockings, which received strong support. Approval for up to 1.5 million options for Hockings drew more opposition, with about 28% of votes cast against; options for Professor Ian Constable received about 35% opposition.

Source announcements: 2026-11-12 08:26 to 2026-11-12 13:24 Sydney time
Story updated 2026-11-12 13:31 Sydney time
Sources2026 Annual General Meeting Program and CEO PresentationResults of Annual General Meeting
Comments